Joe W Gray Selected Research

Polyomavirus Transforming Antigens

4/2004

Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joe W Gray Research Topics

Disease

128	Neoplasms (Cancer) 07/2022 - 07/2002
89	Breast Neoplasms (Breast Cancer) 07/2022 - 04/2002
14	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 07/2002
8	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2007
8	Carcinogenesis 01/2014 - 04/2003
6	Carcinoma (Carcinomatosis) 01/2012 - 04/2004
6	Ovarian Epithelial Carcinoma 02/2009 - 11/2004
3	Triple Negative Breast Neoplasms 10/2021 - 04/2013
3	Disease Progression 02/2020 - 10/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2002
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 10/2009
3	Adenocarcinoma 12/2018 - 04/2011
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 01/2012
3	Colorectal Neoplasms (Colorectal Cancer) 11/2015 - 09/2006
3	Sarcoma (Soft Tissue Sarcoma) 06/2015 - 11/2005
2	Genomic Instability 01/2018 - 01/2004
2	Leukemia 01/2018 - 11/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2011 - 06/2004
2	Lymphoma (Lymphomas) 02/2007 - 01/2004
2	Chromosomal Instability (Chromosome Stability) 04/2006 - 04/2003
1	Bites and Stings (Sting) 10/2021
1	Liver Neoplasms (Liver Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 10/2021 - 07/2002
27	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2003
20	Pharmaceutical PreparationsIBA 01/2022 - 04/2006
17	Biological ProductsIBA 03/2021 - 03/2006
17	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2006
13	Small Interfering RNA (siRNA)IBA 01/2022 - 09/2005
13	Messenger RNA (mRNA)IBA 01/2017 - 11/2004
11	Estrogen ReceptorsIBA 01/2020 - 01/2007
10	Hormones (Hormone)IBA 01/2020 - 01/2007
9	Phenobarbital (Luminal)FDA Link 01/2017 - 01/2009
7	Lapatinib (GW572016)FDA Link 11/2019 - 07/2010
7	RNA (Ribonucleic Acid)IBA 10/2018 - 11/2004
6	Trastuzumab (Herceptin)FDA Link 01/2022 - 07/2010
6	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2014 - 07/2002
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 09/2015
5	Eosine Yellowish-(YS) (Eosin)IBA 10/2020 - 12/2011
5	Hematoxylin (Haematoxylon)IBA 10/2020 - 12/2011
4	AntibodiesIBA 01/2022 - 12/2010
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2014
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2010
4	Estrogens (Estrogen)FDA Link 09/2015 - 10/2011
4	Tamoxifen FDA LinkGeneric 11/2014 - 01/2007
4	Indicators and Reagents (Reagents)IBA 07/2012 - 03/2006
4	Transcription Factors (Transcription Factor)IBA 07/2012 - 04/2007
3	LigandsIBA 09/2021 - 03/2010
3	Tyrosine Kinase InhibitorsIBA 02/2020 - 11/2006
3	Mitogen-Activated Protein KinasesIBA 12/2019 - 07/2012
3	PhosphoproteinsIBA 10/2016 - 01/2015
3	OligonucleotidesIBA 04/2016 - 04/2006
3	Laminin (Merosin)IBA 11/2014 - 02/2006
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2014 - 01/2009
3	Protein Isoforms (Isoforms)IBA 11/2013 - 07/2010
3	Cisplatin (Platino)FDA LinkGeneric 10/2009 - 09/2006
2	pertuzumabIBA 01/2022 - 07/2010
2	taxaneIBA 01/2022 - 02/2009
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021 - 12/2017
2	AntigensIBA 01/2021 - 01/2018
2	ParaffinIBA 01/2020 - 02/2009
2	Monomeric GTP-Binding ProteinsIBA 12/2019 - 11/2004
2	olaparibIBA 12/2017 - 09/2012
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 10/2016
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2017 - 11/2012
2	Growth Factor ReceptorsIBA 01/2017 - 01/2010
2	PolymersIBA 01/2017 - 05/2015
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2017 - 05/2015
2	ChromatinIBA 10/2016 - 11/2014
2	human ERBB2 proteinIBA 09/2014 - 09/2012
2	Ligases (Synthetase)IBA 01/2014 - 04/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2012 - 01/2007
2	Genetic Markers (Genetic Marker)IBA 01/2012 - 12/2009
2	Integrin beta1IBA 07/2010 - 02/2006
2	ClaudinsIBA 07/2010 - 05/2009
2	EphA2 ReceptorIBA 03/2010 - 08/2005
2	Ephrin-A1 (Ephrin A1)IBA 03/2010 - 08/2005
2	Cyclin D1IBA 06/2009 - 09/2005
2	CyclinsIBA 06/2009 - 01/2004
2	PlatinumIBA 02/2009 - 09/2006
2	Peptide Elongation Factors (Elongation Factor)IBA 10/2008 - 07/2002
2	Asparaginase (Elspar)FDA Link 11/2006 - 04/2006
2	EnzymesIBA 11/2006 - 04/2006
2	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 11/2006 - 04/2006
1	venetoclaxIBA 07/2022
1	Drug CombinationsIBA 07/2022
1	PanobinostatIBA 07/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021
1	ChemokinesIBA 09/2021
1	Neuregulin-1 (Neuregulin 1)IBA 01/2021
1	Hyaluronan ReceptorsIBA 01/2021
1	Keratins (Keratin)IBA 10/2020

Therapy/Procedure

55	Therapeutics 07/2022 - 07/2003
9	Drug Therapy (Chemotherapy) 01/2018 - 11/2004
4	Precision Medicine 01/2020 - 01/2015
3	Immunotherapy 07/2022 - 01/2019
3	Radiotherapy 12/2019 - 01/2010
2	Neoadjuvant Therapy 09/2012 - 04/2012
1	Microbubbles 01/2022